ResMed (RMD)

Cost of Revenue

$2.20B

TTM · Period ending: · USD

RMD logo

RMD Cost of Revenue

Latest reported$2.20B
RMD TTM Cost of Revenue ($0.00 → $2.20B)
High-resolution chart · PNG

RMD cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

ResMed Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
50,377,000
38,012,000
34,412,000
31,946,000
30,715,000
29,292,000
27,900,000
26,700,000
25,000,000
23,300,000
21,400,000
20,000,000
19,400,000
18,700,000
18,200,000
17,800,000
17,700,000
17,300,000
17,500,000
13,400,000
9,000,000
4,600,000
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.